title: Sirolimus as primary immunosuppression is effective in attenuating progression of cardiac-allograft vasculopathy.
authors.affiliation: Massachusetts General Hospital, Department of Surgery, Cox 654, 55 Fruit Street, Boston, MA 02114, USA. madsen@helix.mgh.harvard.edu
authors.forename: Joren C
authors.initials: JC
authors.lastname: Madsen